Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€26.17
03.11.21
-
03.11.22
-8.41%
15.11.21

Risky Investment
buy
Promis Neurosciences Inc.

Start price
Target price
Perf. (%)
€6.93
01.11.21
€10.80
01.11.22
-21.90%
05.12.21

ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€25.86
27.10.21
€40.00
31.12.23
-59.32%
08.05.23

Could be very worthwhile Investment >20% year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€30.01
25.10.21
-
25.10.22
-1.37%
31.10.21

buy
Fennec Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.45
18.10.21
€12.00
31.12.23
-2.68%
08.05.23

Could be very worthwhile Investment >20% year
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.49
10.10.21
€5.00
31.12.23
-32.83%
08.05.23

Could be very worthwhile Investment >20% year
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€26.00
05.10.21
-
05.10.22
-10.00%
08.12.21

Probably not worthwhile Investment
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€26.40
04.10.21
-
04.10.22
45.45%
10.08.22

Could be worthwhile Investment >10% per year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€19.92
28.09.21
-
28.09.22
-6.85%
02.10.21

Could be worthwhile Investment >10% per year
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.79
20.09.21
-
20.09.25
-26.16%
03.04.23

Could be worthwhile Investment >10% per year
buy
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€14.20
18.09.21
€40.00
31.12.23
61.97%
16.12.21

Could be very worthwhile Investment >20% year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€13.96
25.08.21
-
25.08.22
4.84%
05.09.21

Risky Investment
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.83
17.08.21
-
17.08.22
-9.02%
22.08.21

buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€9.95
05.08.21
-
05.08.22
23.44%
08.08.21

Could be worthwhile Investment >10% per year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€9.71
15.07.21
-
15.07.22
1.92%
23.04.22

Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.45
10.07.21
€1.90
10.07.22
23.96%
11.11.21

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.39
08.07.21
-
08.07.22
13.98%
08.07.22

buy
Enwave Corporation

Start price
Target price
Perf. (%)
€0.71
01.07.21
€1.10
01.07.22
-35.41%
02.07.22

buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.23
28.06.21
-
28.06.22
-24.89%
29.06.22

buy
Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€1.38
28.06.21
€2.50
28.06.22
-71.16%
29.06.22

Aptose Biosciences

Start price
Target price
Perf. (%)
€3.26
12.06.21
€1.00
12.06.22
-14.11%
26.06.21

buy
Aptose Biosciences

Start price
Target price
Perf. (%)
€3.22
11.06.21
€4.00
11.06.22
-69.57%
14.12.21

Could be worthwhile Investment >10% per year
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€9.52
27.05.21
€32.00
27.05.22
-55.61%
28.05.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Very Future proof/growth oriented business model
buy
Aptose Biosciences

Start price
Target price
Perf. (%)
€4.64
01.05.21
€4.50
01.05.22
-30.60%
11.06.21

Could be worthwhile Investment >10% per year
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€8.92
26.04.21
-
26.04.22
-38.92%
08.02.22